Formulate an advanced drug delivery system that increases the bioavailability of methylene blue, improves hyperphosphorylated tau targeting, enhances magnetic resonance imaging, mitigates neuronal death, and ameliorates AD‐related symptoms. Here, MAPT is linked to Alzheimer disease.